Spectral AI, Inc.

Spectral AI, Inc. (Nasdaq: MDAI) is a medical technology company focused on artificial intelligence-driven wound assessment, with its core platform using multispectral imaging to help clinicians evaluate burn injuries and predict healing outcomes. The company accessed public markets through a SPAC merger and operates within the healthcare technology sector. Its Form 10-Q filed May 13, 2022 (accession no. 0001213900-22-026472) reflects its reporting obligations as a newly public entity in the medical AI space. Spectral AI's technology targets acute wound care at the intersection of clinical diagnostics and machine learning. For full filing history, deal timelines, and SPAC-level analytics on MDAI, sign up for complete data access at SpacDesk.